Uganda mobilises diagnostics supplies and labs support in response to fever outbreak:
This article was originally published in Clinica
Executive Summary
The Ugandan government is mobilising diagnostic testing and laboratory resources to stem an outbreak of Marburg haemorrhagic fever (MHF). The ministry of health (MoH) is acting to monitor and halt a possible spread of the infection beyond a single group of several cases, including one fatality, reported over the last month, according to a statement issued today by the World Health Organisation. The WHO is supporting the MoH with supplies and logistics efforts. The laboratory investigations are being carried out by the Uganda Virology Research Institute and the Kenya Medical Research Institute, backed by the Atlanta, US laboratory of the Centers for Disease Control and Prevention (CDC), where the definitive confirmation of MHF was made.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.